Trademark Overview
On Thursday, April 16, 2026, a trademark application was filed for CYT-108 with the United States Patent and Trademark Office. The USPTO has given the CYT-108 trademark a serial number of 99768532. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, April 16, 2026. This trademark is owned by Cytonics Corporation. The CYT-108 trademark is filed in the Pharmaceutical Products category with the following description:
Biological and pharmaceutical preparations for the treatment of joint disorders, osteoarthritis, musculoskeletal and protease-mediated disorders; Biological and pharmaceutical preparations for inhibiting proteases associated with cartilage degradation in joints; Pharmaceutical preparations for intra articular administration for treatment of joint disorders, osteoarthritis, musculoskeletal and protease-mediated disorders; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration.